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BACKGROUND: Suboptimal maternal folate status is considered a risk factor for neural tube defects (NTDs).
However, the relationship between dietary folate status and risk of NTDs appears complex, as experimen-
tally induced folate deﬁciency is insufﬁcient to cause NTDs in nonmutant mice. In contrast, folate deﬁciency
can exacerbate the effect of an NTD-causing mutation, as in splotch mice. The purpose of the present study
was to determine whether folate deﬁciency can induce NTDs in mice with a permissive genetic background
which do not normally exhibit defects. METHODS: Folate deﬁciency was induced in curly tail and genetically
matched wild-type mice, and we analyzed the effect on maternal folate status, embryonic growth and devel-
opment, and frequency of NTDs. RESULTS: Folate-deﬁcient diets resulted in reduced maternal blood folate,
elevated homocysteine, and a diminished embryonic folate content. Folate deﬁciency had a deleterious effect
on reproductive success, resulting in smaller litter sizes and an increased rate of resorption. Notably, folate
deﬁciency caused a similar-sized, statistically signiﬁcant increase in the frequency of cranial NTDs among
both curly tail (Grhl3 mutant) embryos and background-matched embryos that are wild type for Grhl3. The
latter do not exhibit NTDs under normal dietary conditions. Maternal supplementation with myo-inositol
reduced the incidence of NTDs in the folate-deﬁcient wild-type strain. CONCLUSIONS: Dietary folate deﬁ-
ciency can induce cranial NTDs in nonmutant mice with a permissive genetic background, a situation that
likely parallels gene-nutrient interactions in human NTDs. Our ﬁndings suggest that inositol supplementa-
tion may ameliorate NTDs resulting from insufﬁcient dietary folate. Birth Defects Research (Part A) 88:76–83,
2010.  2009 Wiley-Liss, Inc.
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INTRODUCTION
Maternal nutritional status is thought to play a key
role in embryonic development and determination of
pregnancy outcome. In particular, attention has focused
on folic acid, a vitamin whose biologic derivatives, fo-
lates, are integral to the interlinked folate and methionine
cycles that make up one-carbon metabolism (Blom et al.,
2006; Beaudin and Stover 2009). Maternal folic acid sup-
plementation during early pregnancy reduces the risk of
neural tube defects (NTDs; see Blom et al., 2006 and Mol-
loy et al., 2009 for reviews). Spina biﬁda and anence-
phaly, the most frequent NTDs, result from failure of clo-
sure of the neural tube during embryogenesis and are
among the commonest human birth defects (Copp et al.,
2003; Greene and Copp, 2009). Additional evidence for
the potential importance of adequate folate one-carbon
metabolism in neural tube closure comes from the ﬁnd-
ing that indicators of suboptimal folate status, such as
low serum folate levels or elevated plasma homocysteine,
are risk factors for NTDs (Kirke et al., 1993; Mills et al.,
1995). Polymorphisms in certain enzymes of folate one-
carbon metabolism are associated with increased risk of
NTDs in certain populations (Boyles et al., 2005; Molloy
et al., 2009). Moreover, some NTD cases may be associ-
ated with an underlying defect in folate metabolism in
the fetus itself (Dunlevy et al., 2007).
Maternal folate levels in most NTD-affected pregnan-
cies do not correspond to overt folate deﬁciency and lie
within what is considered the ‘normal’ range (Scott,
1999). However, there is an apparent relationship
between maternal folate status and NTD risk (Daly et al.,
1995; Shaw et al., 1995), suggesting that low folate status
may increase susceptibility. Possible effects of limited fo-
late availability on neural tube closure have been investi-
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folates are dietary (food folates and synthetic folic acid
supplements) and from bacterial microﬂora of the large
intestine (Rong et al., 1991; Beaudin and Stover, 2009).
Therefore, induction of severe folate deﬁciency in experi-
mental models requires the use of a folate-deﬁcient diet
in combination with antibiotics (Burgoon et al., 2002; Bur-
ren et al., 2008). Imposition of maternal folate deﬁciency
in ‘normal’ inbred mouse strains, Swiss-Webster and
ICR, resulted in growth retardation and reduced weight
of offspring, as well as an increased rate of resorption
(Heid et al., 1992; Burgoon et al., 2002). However, NTDs
were not observed in these studies.
The ﬁnding of overlapping maternal folate levels
between normal and NTD pregnancies in humans, and
the inability of severe folate deﬁciency to cause NTDs in
nonmutant mice, argues against the idea that folate deﬁ-
ciency alone is a major cause of NTDs. Instead, it is
hypothesized that a proportion of NTDs may result from
a gene-environment interaction, in which suboptimal fo-
late status exacerbates an underlying genetic predisposi-
tion. This idea received support from recent studies in
which maternal folate deﬁciency was found to increase
the rate of cranial NTDs in Pax3 (splotch; Sp
2H) mutant
embryos (Burren et al., 2008; Greene et al., 2009). In con-
trast, wild-type littermates did not display NTDs when
folate deﬁcient, suggesting that NTDs in the mutant
embryos resulted from an interaction of folate deﬁciency
with NTD predisposition, imposed by loss of Pax3 func-
tion. In addition to an exacerbating effect of folate deﬁ-
ciency, NTDs in splotch embryos developing under nor-
mal ‘folate-replete’ conditions may be further ameliorated
by supplemental folic acid (Fleming and Copp, 1998;
Wlodarczyk et al., 2006).
The increased penetrance of cranial NTDs in Pax3 mu-
tant embryos demonstrates that folate deﬁciency can
increase susceptibility to NTDs. However, rather than
involving a single gene, the majority of human NTDs are
thought to result from the interaction of multiple predis-
posing genetic factors, plus a possible contribution of
environmental factors (Harris and Juriloff, 2007). There-
fore, to more accurately model this etiology, we decided
to test whether folate deﬁciency is sufﬁcient to induce
NTDs in a mouse strain in which NTDs never arise
under normal dietary conditions, but which carries ‘sus-
ceptibility’ modiﬁer genes proven to enhance NTDs in
the context of a major genetic mutation.
For this purpose we used a wild-type mouse strain,
denoted 1
ct/1
ct, that shares the genetic background of the
curly tail (ct/ct) NTD mutant strain. Homozygous curly tail
(ct/ct) embryos develop spina biﬁda (approximately 15–20%
penetrance), tail ﬂexion defects (approximately 50%), and
infrequent exencephaly (Van Straaten and Copp, 2001). The
curly tail gene, ct, corresponds to a hypomorphic allele of
the transcription factor grainyhead-like-3 (Grhl3) (Ting et al.,
2003; Gustavsson et al., 2007). However, genetic modiﬁers
in the curly tail strain also have a major effect on penetrance
of spinal NTDs (Neumann et al., 1994; Letts et al., 1995;
Gustavsson et al., 2008). We previously generated the genet-
ically matched, partially congenic, wild-type strain
(1
ct/1
ct) by successive back-crossing to the ct strain, having
ﬁrst replaced the ct allele of Grhl3 with a wild-type allele.
The 1
ct/1
ct strain is predicted to share 96% of the curly tail
genetic background (Van Straaten and Copp, 2001; Gustavs-
son et al., 2007). Embryos of the 1
ct/1
ct strain do not de-
velop NTDs or tail ﬂexion defects, but, as they carry modi-
ﬁer genes from the curly tail background, we reasoned that
embryos may exhibit predisposition to NTDs caused by an
environmental insult such as folate deﬁciency.
Although spinal NTDs in the curly tail mutant are ame-
nable to prevention by certain exogenous agents, includ-
ing inositol and retinoids, there is no protective effect of
folic acid, and curly tail has therefore been used as a
model for ‘folate-resistant’ NTDs (Seller, 1994; Chen
et al., 1994; Greene and Copp, 1997, 2005). However, the
effect of folate deﬁciency has not been investigated in
curly tail, and the present study provided an opportunity
to ask whether folate deﬁciency can exacerbate NTDs, in
a mutant mouse strain in which spinal NTDs are not pre-
ventable by supplemental folic acid (folate resistant). Our
ﬁndings demonstrate a deleterious effect of dietary folate
deﬁciency on cranial neural tube closure, with an
enhanced frequency of exencephaly in both curly tail mu-
tant embryos and the congenic wild-type (1
ct/1
ct) strain
in which NTDs never normally occur.
MATERIALS AND METHODS
Maintenance of Mice and Dietary Conditions
Curly tail (ct/ct) and genetically matched wild-type
(1
ct/1
ct) mice were maintained as random-bred, homo-
zygous colonies. Mice were routinely fed a standard
breeding diet (Harlan Teklad) containing 2.7 mg/kg folic
acid. For dietary studies, female mice were randomly
allocated at 6 weeks of age to the standard diet (SD) or
to one of three synthetic protein-based diets that were
matched to the standard diet for micronutrient levels,
with the exception of folic acid, as used previously
(Burren et al., 2008). No folic acid was present in diet FD
(folate deﬁcient), which also contained the antibiotic 1%
succinyl sulfathiazole (10 gm/kg) to produce the most
profound folate deﬁciency. Two control diets were
FD1BF (folate deﬁcient with bacterially derived folate),
which lacked folate but with omission of antibiotic, and
FD1DF (folate deﬁcient with dietary folate), which con-
tained the same level of folic acid as the standard breed-
ing diet, but with the addition of antibiotic. Females were
maintained on each diet for a minimum of four weeks
before mating to SD-fed males.
Supplementation of Experimental Litters
and Embryo Analysis
Experimental litters were generated by overnight mat-
ings, the day of ﬁnding a copulation plug being desig-
nated embryonic day 0.5 (E0.5). In vivo supplementation
was by intra-peritoneal injection, daily from E7.5–10.5,
using 1 mg/ml folic acid (Sigma) in sterile phosphate
buffered saline (PBS), to a dose of 10 mg/kg, or 40 mg/
ml myo-inositol (Sigma) in PBS, to a dose of 400 mg/kg.
Pregnant females were killed by cervical dislocation.
Embryos were dissected from the uterus in Dulbecco’s
Modiﬁed Eagle’s Medium (Invitrogen) containing 10% fe-
tal calf serum, and inspected carefully to detect any
abnormalities of neural tube closure. Somite number and
crown-rump length were determined as described
previously (Brown, 1990). Embryos were then rinsed in
PBS and immediately frozen on dry ice for biochemical
analysis.
77 GENETIC SUSCEPTIBILITY TO EXENCEPHALY
Birth Defects Research (Part A) 88:7683 (2010)Quantiﬁcation of Folate and Homocysteine in
Maternal Blood and Embryos
Mice were anesthetized with halothane, and blood was
collected by cardiac puncture and immediately trans-
ferred to lithium-heparin coated tubes (Microtainer, BD).
Whole blood folate was measured using the L. casei
microbiologic method (Molloy and Scott, 1997). A second
aliquot was centrifuged, and plasma was stored at 2708C
before quantiﬁcation of homocysteine by standard meth-
ods (Leino, 1999). Embryonic folate was measured using
an adapted version of the L. casei microbiologic method
(Molloy and Scott, 1997), as described previously (Burren
et al., 2008).
Statistical Analysis
Comparisons were performed between treatment
groups by ANOVA, t test (for pairwise comparisons), or
z-test (comparison of NTD frequencies), computed using
Sigmastat (version 3.5, Systat Software) and/or SPSS
(version 13).
RESULTS
Folate-Deﬁcient Diets Lower Maternal Blood
Folate and Elevate Homocysteine
Dietary folate deﬁciency was induced in wild-type
(1
ct/1
ct) and curly tail (ct/ct) female mice, by mainte-
nance on a synthetic folate-free diet including antibiotics
(designated FD) for a minimum of four weeks before
mating. As in our previous study of splotch mice (Burren
et al., 2008), these conditions resulted in a signiﬁcant
reduction in maternal whole blood folate level, compared
to a standard breeding diet (SD) (Fig. 1A). A control diet
(FD1DF) that included folic acid, but with antibiotic to
remove bacterial folate, resulted in a less severe reduc-
tion in maternal blood folate levels. In contrast, omission
of dietary folate, without addition of antibiotics (FD1BF),
had an effect of similar magnitude as the FD diet (Fig.
1A).
In parallel with reduction of maternal blood folate, the
FD diet also resulted in a signiﬁcant elevation of mater-
nal homocysteine (Fig. 1B). Homocysteine was also
signiﬁcantly elevated, but to a lesser extent, in mice
maintained on the FD1DF and FD1BF diets, in which ei-
ther bacterial folate or dietary folate were omitted (Fig.
1B).
Decreased Reproductive Performance in
Folate-Deﬁcient Pregnancies
Previously, using the same dietary conditions, we
found no effect of folate deﬁciency on litter size or
resorption rate in Pax3 mutant splotch (Sp
2H) mice (Burren
et al., 2008). In contrast, folate deﬁciency had a deleteri-
ous effect on reproductive success in 1
ct/1
ct and curly
tail pregnancy. Among litters analyzed at E11.5, folate
deﬁciency resulted in a signiﬁcant reduction in the num-
ber of implantations per litter and an increase in the
number of resorptions (Table 1). This sensitivity to folate
status seems to be a feature of the ct genetic background
because litters of both 1
ct/1
ct and ct/ct strains appeared
equally affected. The deleterious effects of folate deﬁ-
ciency on embryonic viability appeared to worsen pro-
gressively during development because, among litters
collected at E13.5 (n 5 5 1
ct/1
ct and 6 ct/ct), very few
viable embryos were observed, whereas the resorption
rate was very high (5.5 6 0.6 and 5.8 6 1.3 per litter,
respectively).
Figure 1. Effect of dietary folate deﬁciency on maternal blood fo-
late (A) and plasma homocysteine (B). Folate-deﬁcient (FD) condi-
tions, imposed by a folate-free diet containing antibiotic, resulted
in a signiﬁcant reduction in maternal whole blood folate com-
pared to standard diet (SD) and a signiﬁcant increase in maternal
plasma homocysteine. Inclusion of either dietary folate (FD1DF)
or omission of antibiotic (FD1BF) had an intermediate effect on
both maternal folate and homocysteine level. Signiﬁcant differen-
ces compared to SD are indicated by * (p < 0.05) or ** (p < 0.001).
Signiﬁcant difference compared to FD diet is indicated by # (p <
0.05). No signiﬁcant differences were observed between the
1
ct/1
ct and ct/ct strains for any of the dietary conditions.
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determined crown-rump length and number of somites,
respectively, of embryos at E10.5 that had developed
under differing dietary conditions. Compared to the
standard diet, folate deﬁciency resulted in a signiﬁcant
reduction in crown-rump length and number of somites
in both 1
ct/1
ct and ct/ct strains (Fig. 2). Thus, FD condi-
tions appeared to dissociate gestational age from embry-
onic growth and developmental progression such that,
by E10.5, the size and somite stage of FD embryos corre-
sponded to approximately 24 hours developmental delay
compared to standard conditions. Inclusion of dietary fo-
late or omission of antibiotics (FD1DF and FD1BF) sig-
niﬁcantly enhanced growth parameters compared to FD
conditions (Fig. 2).
Embryonic Folate Content, but Not Folate
Concentration, Is Diminished in Folate Deﬁciency
Somite-matched 1
ct/1
ct and ct/ct embryos were ana-
lyzed to determine the effect of FD conditions on embry-
onic folate content and concentration. The total folate
content of 26–32 somite FD embryos was signiﬁcantly
diminished compared to embryos that developed under
standard conditions (Table 2), despite the fact that FD
embryos were gestationally older than SD embryos at the
same somite stage. In contrast, folate concentration (nor-
malized to protein content of the embryo) did not differ
signiﬁcantly between dietary groups because protein con-
tent was also lower in FD conditions. These ﬁndings sug-
gest that folate availability places a limit on growth and
developmental progression during mouse embryogenesis.
Folate Deﬁciency Causes Cranial NTDs
in 1
ct/1
ct and ct/ct Embryos
We examined embryos at E11.5 to determine whether
neural tube closure was compromised by development
under FD conditions. Remarkably, we observed cranial
NTDs (exencephaly) among 1
ct/1
ct embryos, whereas
this strain has never been found to develop NTDs under
normal dietary conditions, either in this (Fig. 3) or in pre-
vious studies. A lower frequency of cranial NTDs was
Table 1
Impact of Folate-Deﬁcient Diets on Litter Size and
Resorption Rate
Strain Diet No. litters
Total
implants
Implants
per litter
Resorptions
per litter
1
ct/1
ct SD 15 102 6.8 6 0.8 0.7 6 0.3
FD 14 68 4.9 6 0.7 2.0 6 0.7*
FD1DF 4 21 5.3 6 0.7 1.0 6 0.2
FD1BF 4 23 5.8 6 0.3 2.0 6 0.3*
ct/ct SD 17 123 7.2 6 0.1 0.9 6 0.2
FD 20 106 5.3 6 0.5* 2.3 6 0.4*
FD1DF 7 47 6.7 6 0.3 1.1 6 0.2#
FD1BF 7 46 6.6 6 0.3 1.9 6 0.2*
Total number of implantations and number of resorptions was
recorded for litters collected at E11.5. Values are given as mean 6
SEM. FD conditions resulted in smaller litter size and increased
resorption rate (* indicates signiﬁcant difference from SD, p <
0.05, ANOVA). The inclusion of dietary folate (FD1DF) reduced
the resorption rate (# signiﬁcant difference compared with FD, p <
0.05), whereas omission of antibiotic did not (* signiﬁcant differ-
ence from SD, p < 0.05). No signiﬁcant differences were observed
between 1
ct/1
ct and ct/ct litters for any parameter.
Figure 2. Dietary folate deﬁciency causes embryonic growth re-
tardation. The growth and developmental progression of 1
ct/1
ct
and ct/ct embryos were assessed at E10.5 by analysis of
(A) crown-rump length and (B) somite number. The folate-deﬁ-
cient diet (FD) resulted in a signiﬁcant reduction in both param-
eters (**p < 0.02, compared to all other groups of same geno-
type). Inclusion of either dietary folate (FD1DF) or bacterial
folate (FD1BF) improved both growth and developmental pro-
gression. However, crown-rump length and number of somites
remained signiﬁcantly lower for embryos on the FD1BF diet
compared to standard (SD) conditions (*p < 0.02). No signiﬁcant
differences were observed between 1
ct/1
ct and ct/ct strains for
any of the dietary conditions.
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ct/1
ct embryos developing under
FD1DF or FD1BF conditions. The order of diets in terms
of increasing incidence of NTDs—from SD (no NTDs),
FD1DF, FD1BF, to FD (highest frequency)—correlates
with the order of decline in maternal blood folate levels.
Spinal NTDs were not observed among 1
ct/1
ct embryos
(n 5 15 FD embryos at stages at which the spinal neural
tube is expected to be closed).
Curly tail (ct/ct) mutant embryos displayed a low fre-
quency (11%) of cranial NTDs under normal dietary con-
ditions (Fig. 3), as reported previously (Van Straaten and
Copp 2001). However, folate deﬁciency caused a dra-
matic increase in the frequency of cranial NTDs in ct/ct
embryos to more than 50% (Fig. 3). This effect was not
observed when folic acid was included in the diet
(FD1DF), correlating with an elevation of maternal blood
folate (Fig. 1A). In contrast, cranial NTDs still occurred at
high frequency when bacterial folate was available
because of omission of antibiotic (Fig. 3; FD1BF), again
correlating with an apparent lack of difference between
FD and FD1BF conditions in effect on maternal blood fo-
late (Fig. 1A). Although many embryos were develop-
mentally delayed we could assess posterior neuropore
closure among embryos that had 32 or more somites.
Spina biﬁda was observed in 6 of 21 (28.6%) folate-deﬁ-
cient ct/ct embryos, which does not differ signiﬁcantly
from the typical 20% frequency that was observed among
curly tail embryos developing under standard dietary
conditions.
A comparison of the effect of FD diet on the differ-
ent strains showed that exencephaly was signiﬁcantly
more frequent among FD ct/ct embryos than 1
ct/1
ct
(55% compared to 29%; p < 0.01). However, taking into
consideration the baseline 11% exencephaly rate among
ct/ct embryos, observed even under SD conditions,
there was no signiﬁcant difference between strains in
the increase in NTD frequency attributable to folate
deﬁciency.
Finally, we tested whether maternal supplementation
with either folic acid or myo-inositol would reduce the
detrimental effects of dietary folate deﬁciency. In 1
ct/
1
ct embryos, treatment of pregnant dams with myo-ino-
sitol abolished cranial NTDs (p < 0.02; Fig. 3). Folic
acid supplementation caused a statistically nonsigniﬁ-
cant reduction in frequency, concomitant with an
increase in embryonic folate content (Table 2). The fre-
quency of cranial NTDs in ct/ct mutants was lower
when dams were supplemented with folic acid or myo-
inositol (Fig. 3), but neither effect reached statistical
signiﬁcance.
Table 2
Embryonic Folate Content and Concentration in 1
ct/1
ct and ct/ct Embryos
Strain Diet No. embryos
No. somites
Mean (range)
Folate content
(pg/embryo)
Folate concentration
(pg/mg protein)
1
ct/1
ct SD 18 29.8 (26–32) 8244 6 445 30.1 6 3.3
FD 13 28.0 (26–32) 5184 6 282* 37.3 6 1.3
FD1FA 5 28.8 (26–32) 13,675 6 598
#* 49.0 6 9.2*
ct/ct SD 10 28.4 (26–32) 8822 6 1527 28.8 6 3.2
FD 14 29.1 (26–32) 5065 6 419* 23.4 6 5.6
FD1FA 7 28.1 (26–32) 8877 6 975
# 56.0 6 7.9
#
Total folate content (mono- and polyglutamates) was determined in embryos from the standard diet (SD) and folate-deﬁciency (FD)
groups that had reached an equivalent developmental stage (somite-stage matched). Values are given as mean 6 SEM. Folate content
did not differ between genotypes but was signiﬁcantly diminished in FD conditions (*p < 0.05 compared with SD). Folate concentration
did not differ either between genotypes or dietary groups. Folic acid treatment (FD1FA) resulted in a signiﬁcant increase in folate con-
tent compared with untreated folate-deﬁcient embryos (#p < 0.05 compared with FD).
Figure 3. Folate deﬁciency increases the risk of cranial NTDs
among 1
ct/1
ct and ct/ct embryos. Development on the folate-
deﬁcient (FD) diet resulted in an increased frequency of cranial
NTDs among both 1
ct/1
ct and ct/ct embryos (* indicates signiﬁ-
cant difference compared to SD, p < 0.001). Inclusion of folic
acid in the diet (FD1DF) reduced the incidence of cranial NTDs
(# signiﬁcant difference compared to FD, p < 0.001), whereas re-
moval of antibiotic (FD1BF) had a lesser, nonsigniﬁcant effect.
The frequency of cranial NTDs appeared lower in embryos fol-
lowing maternal supplementation with folic acid (FD1FA) or
myo-inositol (FD1MI), although only the protective effect of
myo-inositol in 1
ct/1
ct embryos was statistically signiﬁcant (#
compared to FD, p < 0.02). Number of embryos in which cranial
neural tube closure was assessed, in order of x-axis group:
1
ct/1
ct 5 102, 48, 17, 15, 17, 26; ct/ct 5 126, 92, 36, 23, 23, 22.
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In mammals, folates cannot be synthesized de novo
and must be obtained from exogenous sources via intesti-
nal absorption. Polyglutamated folates are converted to
monoglutamates for absorption and circulate in the se-
rum predominantly as 5-methyl-tetrahydrofolate. Cellular
folate appears essential for embryonic survival and neu-
ral tube closure because a proportion of embryos lacking
folate receptor 1 (Folr1) develop NTDs, when rescued
from lethality by administration of folinic acid (Piedra-
hita et al., 1999; Spiegelstein et al., 2004). Nevertheless,
elucidation of a link between dietary folate deﬁciency
and risk of NTDs has proven more elusive.
In the present study, maintenance of female 1
ct/1
ct or
ct/ct mice on a folate-deﬁcient diet, containing antibiotic
to deplete the intestinal microﬂora, resulted in reduced
blood folate and elevated plasma homocysteine, conﬁrm-
ing previous ﬁndings of ourselves and others (Burgoon
et al., 2002; Burren et al., 2008). This experimental model
recapitulates features associated with suboptimal dietary
folate status in human NTDs. However, despite causing
severe folate deﬁciency and embryonic growth retarda-
tion, NTDs have never been induced in nonmutant
strains (Heid et al., 1992; Burgoon et al., 2002; Burren
et al., 2008).
It was particularly striking, therefore, that in the pres-
ent study folate deﬁciency proved sufﬁcient to cause cra-
nial NTDs in 1
ct/1
ct embryos, a nonmutant strain that
does not exhibit NTDs under standard dietary condi-
tions. Previously we observed an enhanced frequency of
cranial NTDs in splotch embryos, both homozygous
(Sp
2H/Sp
2H) and heterozygous (Sp
2H/1), developing under
folate-deﬁcient conditions (Burren et al., 2008). Similarly,
in the SELH/Bc mouse strain, risk of cranial NTDs is
determined not only by a combination of genes at three
different loci, but also by diet (although not by folate
level) (Juriloff et al., 2001; Harris and Juriloff, 2005).
Therefore, we hypothesize that folate-related NTDs in
1
ct/1
ct embryos result, as in splotch and SELH/Bc, from
gene-environment interactions. The difference in the case
of 1
ct/1
ctembryos, however, is that the genetic risk fac-
tors are insufﬁcient to cause NTDs by themselves. This
latter etiology may well parallel the situation in humans
in which suboptimal folate status (or other dietary fac-
tors) enhances susceptibility to NTDs when present in
combination with genetic risk factors that may not be
causative under folate-replete conditions.
Although 1
ct/1
ct embryos are wild type for Grhl3, the
major curly tail gene, predisposing modiﬁers are known
to be present in the curly tail genetic background, with at
least three risk loci for spinal NTDs having been mapped
(Neumann et al., 1994; Letts et al., 1995). Findings of the
current study indicate that the ct strain genetic back-
ground also contains susceptibility loci for folate-related
cranial NTDs. It is plausible that a common set of genetic
risk factors may inﬂuence both cranial and spinal neural
tube closure in curly tail mice, because exencephaly and
spina biﬁda occur together in a number of mouse
mutants (Copp et al., 2003). However, at present it is not
known whether any or all of the modiﬁers that inﬂuence
penetrance of spinal NTDs in curly tail mice are the same
as those that are permissive for folate-deﬁciency-induced
exencephaly. The effect of dietary folate deﬁciency on
neural tube closure has been investigated in several
mouse strains, including Swiss-Webster (Heid et al.,
1992), ICR (Burgoon et al., 2002), Sp wild-type (C57BL/6
background; Li et al., 2006), Sp
2H wild-type (mixed
CBA/101 and C3H background; Burren et al., 2008), and
CD1 (our unpublished data). Although folate deﬁciency
does not cause NTDs in any of these strains, it is possible
that the folate-sensitivity variants in the ct genetic back-
ground (mixed CBA/Gr and GFF) will prove to be pres-
ent in other as yet untested strains.
It is informative to compare the predisposition to cra-
nial NTDs in the different curly tail (Grhl3)-related strains
that have been described to date. Two independent Grhl3
gene knockouts exist, which exhibit 2% and 14% exence-
phaly, respectively (Ting et al., 2003; Yu et al., 2006).
NTDs in the former strain are resistant to folic acid sup-
plementation, whereas the effect of folate deﬁciency on
Grhl3 null embryos has not been reported. In our studies
the ct/ct mutant, which is a hypomorphic allele of Grhl3,
exhibited a very similar (11%) frequency of cranial NTDs
as the gene knockouts, but with an exacerbation to 55%
when folate deﬁcient. Moreover, the 1
ct/1
ct congenic
strain, which is wild type at the Grhl3 locus but incorpo-
rates essentially all of the curly tail genetic background
modiﬁers, developed no cranial NTDs under folate-
replete conditions, but exhibited exencephaly in 29% of
cases when folate deﬁcient. Given this comparison, it is
tempting to attribute the great majority of the predisposi-
tion to cranial NTDs to the genetic background effect,
although having a loss-of-function Grhl3 allele clearly
imparts a minor risk of cranial NTD.
The occurrence of spinal NTDs (open spina biﬁda) pro-
vides a sharp contrast to the situation with cranial NTDs.
Both of the Grhl3 gene knockout strains exhibit 100%
spina biﬁda (Ting et al., 2003; Yu et al., 2006), whereas
the hypomorphic ct/ct strain typically shows 15–20%
spina biﬁda, and the 1
ct/1
ct congenic strain does not ex-
hibit spinal NTDs at all. Although the limited period of
embryo viability hampered our analysis of spinal neural
tube closure in folate-deﬁcient litters, there appeared to
be no exacerbation of spina biﬁda by folate deﬁciency in
the ct/ct strain nor in folate-deﬁcient 1
ct/1
ct litters,
where spina biﬁda was never observed. Hence, the risk
of spinal NTDs appears to be predominantly determined
by the degree of loss of Grhl3 function. Differential regu-
lation of NTDs in the cranial and spinal regions is also
observed in the very different response of curly tail mice
to retinoic acid (RA) treatment. Exogenous RA was found
to exacerbate cranial NTDs when administered on day 8,
the critical stage for cranial neurulation, whereas spinal
NTD frequency was reduced by RA on day 9, the key
stage for spinal closure (Seller et al., 1979; Seller and Per-
kins, 1982; Chen et al., 1994). It now seems likely that RA
may interact with cranial and spinal closure via two dif-
ferent embryonic mechanisms that have distinct genetic
regulatory requirements.
In a previous study, a low-folate diet had no effect on
NTD frequency in ct/ct embryos (Tran et al., 2002). How-
ever, the diets used in that study contained minimal lev-
els of folic acid (0.3 mg/kg) and no antibiotics, suggest-
ing that residual folate may have been available. The lack
of effect on NTD incidence thus correlates with our ﬁnd-
ing that availability of even low levels of dietary folate
appears sufﬁcient to enable neural tube closure and dra-
matically enhance embryonic folate content (current
study and Burren et al., 2008).
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a signiﬁcant decrease in litter size and an increase in
resorption rate in the FD diet group, suggesting that fo-
late deﬁciency results in embryonic lethality. This ﬁnding
differs from our previous study in which there was no
effect on litter size, using the same dietary model in
splotch mice (Burren et al., 2008). This observation sug-
gests that the curly tail genetic background confers a par-
ticularly high sensitivity to folate-deﬁcient conditions,
which appears to reﬂect a requirement of the embryo
because maternal blood folate levels in ct/ct and 1
ct/
1
ctmice are affected by the FD diet to a similar extent as
other strains (unpublished observations). The reduced
survival of folate-deﬁcient ct/ct and 1
ct/1
ct embryos may
reﬂect the severe growth retardation and developmental
delay that was observed among surviving embryos.
Although most embryos analyzed at E10.5–11.5 had
reached a developmental stage (judged by somite num-
ber) at which the cranial neural folds should have been
closed, the developmental delay suggests that the process
of cranial neurulation would have occurred over a longer
period. We hypothesize that cranial NTDs in folate-deﬁ-
cient conditions occur as a result of reduced proliferation
associated with growth retardation. In support of this
idea, the incidence of cranial NTDs in ct/ct embryos was
previously found to be enhanced by treatment with
inhibitors of DNA synthesis such as hydroxyurea, mito-
mycin C, or 5-ﬂuorouracil (Seller and Perkins, 1983,
1986).
Much of the effect of the FD diet on neural tube clo-
sure in this study appeared to be due to lack of dietary
folate as opposed to removal of gut bacteria, because
inclusion of folic acid in the diet was sufﬁcient to virtu-
ally eliminate NTDs, even when antibiotics were
included. Maternal supplementation with folic acid by
intra-peritoneal injection produced a small but nonsigniﬁ-
cant reduction in the incidence of exencephaly and,
hence, was less effective than inclusion of folic acid in
the diet throughout gestation. It is possible that embryos
may already have been developmentally retarded by
E7.5, at which point initiation of folic acid treatment was
insufﬁcient to normalize development. Remarkably, myo-
inositol supplementation was able to prevent folate-
related NTDs in 1
ct/1
ct embryos, although not signiﬁ-
cantly in ct/ct embryos. Inositol has previously been
found to prevent spinal NTDs in curly tail mice, whereas
FA has no protective effect (Greene and Copp, 1997;
Cogram et al., 2004). A requirement for inositol in cranial
neurulation has also been demonstrated: inositol deﬁ-
ciency causes cranial NTDs in mice, even among nonmu-
tant strains (Cockroft et al., 1992). Inositol supplementa-
tion also has a protective effect against diabetes-induced
cranial NTDs in rats, possibly through overcoming inosi-
tol depletion related to hyperglycaemia (Reece et al.,
1997; Khandelwal et al., 1998). Interestingly, folic
acid has also been found to reduce the frequency of
diabetes-induced NTDs (Oyama et al., 2009). Thus, in dif-
ferent contexts NTDs may be preventable either by folic
acid or by inositol, or by both. The current study
suggests a further possible protective role for inositol
supplementation, in ameliorating NTDs resulting from
folate deﬁciency.
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